AGP Executive Report
Last update: 10 hours agoAI & Mental Health Safety: A new column digs into how generative AI system prompts steer mental-health chat behavior, raising questions about what guidance may cause the model to help—or mislead. Digital Health Regulation: Conneqt Health filed an FDA Pre-Submission for SphygmoCor Cloud, aiming to move its arterial analytics from dedicated hardware to a cloud SaMD platform. Pharma M&A & Supply: Aurobindo Pharma USA got FTC approval to acquire Lannett for $250M, expanding complex generics and adding U.S. manufacturing capacity. Immunology Deal: AbbVie agreed to buy Apogee Therapeutics for $11B, betting its longer-interval IL-13 antibody (zumilokibart) could improve atopic dermatitis dosing. Public Health & Prevention Economics: A WEF report says low-cost prevention—like hearing aids, home safety, and activity programs—could save nearly $6T by 2040. Health Data Privacy: A Petone pharmacy in New Zealand says patient messages were exposed via its website contact form, then scrubbed from the internet. Workplace/Community Health: Goa flagged off four ambulances for highway medical response, while Liberia’s president received a bill to create a national health insurance fund. Health Risks From Chemicals: Australia approved continued restricted use of paraquat and diquat, with critics warning of Parkinson’s-linked exposure. Market Watch: Indian pharma stocks rallied on reports the U.S. FDA is seeking help from Indian makers to address an ifosfamide injection shortage.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
